Document
PGR2022-00014, No. 1055-55 Exhibit - Fu et al, Expression of a Fusogenic Membrane Glycoprotein by an Oncolytic Herpes Simplex Virus Potentiates the Viral Antitumor Effect, 76 MOLECULAR...
Cite Document
PGR2022-00014, No. 1055-55 Exhibit - Fu et al, Expression of a Fusogenic Membrane Glycoprotein by an Oncolytic Herpes Simplex Virus Potentiates the Viral Antitumor Effect, 76 MOLECULAR THERAPY 748 754
+ More Snippets
Document
PGR2022-00014, No. 1057-57 Exhibit - Ebert et al, Syncytia Induction Enhances the Oncolytic Potential of Vesicular Stomatitis Virus in Virotherapy for Cancer, 64 CANCER RESEARCH 3265 32...
Cite Document
PGR2022-00014, No. 1057-57 Exhibit - Ebert et al, Syncytia Induction Enhances the Oncolytic Potential of Vesicular Stomatitis Virus in Virotherapy for Cancer, 64 CANCER RESEARCH 3265 3270 May 2004 (P.
+ More Snippets
Document
PGR2022-00014, No. 1100-100 Exhibit - Ishikawa et al, STING regulates intracellular DNA mediated, type I interferon dependent innate immunity, 461 NATURE 788 792 October 8, 2009 (P.T.A.B...
Cite Document
PGR2022-00014, No. 1100-100 Exhibit - Ishikawa et al, STING regulates intracellular DNA mediated, type I interferon dependent innate immunity, 461 NATURE 788 792 October 8, 2009 (P.T.A.B. Dec. 15, 202
+ More Snippets
Document
PGR2022-00014, No. 1006-6 Exhibit - Curriculum vitae of John C Bell, PhD (P.T.A.B. Dec. 15, 2021)
Cite Document
PGR2022-00014, No. 1006-6 Exhibit - Curriculum vitae of John C Bell, PhD (P.T.A.B. Dec. 15, 2021)
+ More Snippets
Document
PGR2022-00014, No. 1050-50 Exhibit - Wertz et al, Adding genes to the RNA genome of vesicular stomatitis virus positional effects on stability of expression, 7615 J VIROL 7642 50 August 2002...
Cite Document
PGR2022-00014, No. 1050-50 Exhibit - Wertz et al, Adding genes to the RNA genome of vesicular stomatitis virus positional effects on stability of expression, 7615 J VIROL 7642 50 August 2002 (P.T.A.B.
+ More Snippets
Document
PGR2022-00014, No. 1082-81 Exhibit - Study Details for Clinical Trial NCT02620423 Study of Pembrolizumab with REOLYSIN and Chemotherapy in Patients With Advanced Pancreatic Adenoca...
Cite Document
PGR2022-00014, No. 1082-81 Exhibit - Study Details for Clinical Trial NCT02620423 Study of Pembrolizumab with REOLYSIN and Chemotherapy in Patients With Advanced Pancreatic Adenocarcinoma, last update
+ More Snippets
Document
PGR2022-00014, No. 1051-51 Exhibit - Bett et al, Packaging capacity and stability of human adenovirus type 5 vectors, 6710 J VIROL 5911 21 October 1993 (P.T.A.B. Dec. 15, 2021)
Cite Document
PGR2022-00014, No. 1051-51 Exhibit - Bett et al, Packaging capacity and stability of human adenovirus type 5 vectors, 6710 J VIROL 5911 21 October 1993 (P.T.A.B. Dec. 15, 2021)
+ More Snippets
Document
PGR2022-00014, No. 1009-9 Exhibit - British Patent Application GB 1600381 (P.T.A.B. Dec. 15, 2021)
Cite Document
PGR2022-00014, No. 1009-9 Exhibit - British Patent Application GB 1600381 (P.T.A.B. Dec. 15, 2021)
+ More Snippets
Document
PGR2022-00014, No. 1062-62 Exhibit - Rojas et al, Defining Effective Combinations of Immune Checkpoint Blockade and Oncolytic Virotherapy, 2124 CLIN CANCER RES 5543 51 December 201...
Cite Document
PGR2022-00014, No. 1062-62 Exhibit - Rojas et al, Defining Effective Combinations of Immune Checkpoint Blockade and Oncolytic Virotherapy, 2124 CLIN CANCER RES 5543 51 December 2015 (P.T.A.B. Dec. 15,
+ More Snippets
Document
PGR2022-00014, No. 1081-83 Exhibit - Study Details for Clinical Trial NCT02272855 A Study of Combination Treatment With HF10 and Ipilimumab in Patients With Unresectable or Metastatic Mel...
Cite Document
PGR2022-00014, No. 1081-83 Exhibit - Study Details for Clinical Trial NCT02272855 A Study of Combination Treatment With HF10 and Ipilimumab in Patients With Unresectable or Metastatic Melanoma, last u
+ More Snippets
Document
PGR2022-00014, No. 1027-27 Exhibit - Saha et al, The Adenovirus Genome Contributes to the Structural Stability of the Virion, 69 VIRUSES 2014 3563 3583 Sep 24, 2014 (P.T.A.B. Dec. 15, 20...
Cite Document
PGR2022-00014, No. 1027-27 Exhibit - Saha et al, The Adenovirus Genome Contributes to the Structural Stability of the Virion, 69 VIRUSES 2014 3563 3583 Sep 24, 2014 (P.T.A.B. Dec. 15, 2021)
+ More Snippets
Document
PGR2022-00014, No. 1056-56 Exhibit - Nakamori et al, Potent Antitumor Activity After Systemic Delivery of a Doubly Fusogenic Oncolytic Herpes Simplex Virus Against Metastatic Prostate Canc...
Cite Document
PGR2022-00014, No. 1056-56 Exhibit - Nakamori et al, Potent Antitumor Activity After Systemic Delivery of a Doubly Fusogenic Oncolytic Herpes Simplex Virus Against Metastatic Prostate Cancer, 60 THE P
+ More Snippets
Document
PGR2022-00014, No. 1034-34 Exhibit - Jacobs et al, HSV 1 based vectors for gene therapy of neurological diseases and brain tumors Part II Vector Systems and Applications, 15 NEOPLASIA 4...
Cite Document
PGR2022-00014, No. 1034-34 Exhibit - Jacobs et al, HSV 1 based vectors for gene therapy of neurological diseases and brain tumors Part II Vector Systems and Applications, 15 NEOPLASIA 402 416 November
+ More Snippets
Document
PGR2022-00014, No. 1033-33 Exhibit - Majid et al, Recombinant Vesicular Stomatitis Virus VSV and Other Strategies in HCV Vaccine Designs and Immunotherapy Tan SL, Ed HEPATITIS C VIR...
Cite Document
PGR2022-00014, No. 1033-33 Exhibit - Majid et al, Recombinant Vesicular Stomatitis Virus VSV and Other Strategies in HCV Vaccine Designs and Immunotherapy Tan SL, Ed HEPATITIS C VIRUSES GENOMES AND MO
+ More Snippets
Document
PGR2022-00014, No. 1073-73 Exhibit - Msaouel et al, Attenuated oncolytic Measles Virus strains as cancer therapeutics, 139 CURR PHARM BIOTECHNOL 1732 41 July 1, 2012 (P.T.A.B. Dec. 1...
Cite Document
PGR2022-00014, No. 1073-73 Exhibit - Msaouel et al, Attenuated oncolytic Measles Virus strains as cancer therapeutics, 139 CURR PHARM BIOTECHNOL 1732 41 July 1, 2012 (P.T.A.B. Dec. 15, 2021)
+ More Snippets